Filter
1093
Filtered Results: 1093
Text search:
reagents
Featured
Recommendations
131
New Publications
325
Language
Document type
No document type
620
Guidelines
186
Studies & Reports
123
Strategic & Response Plan
69
Manuals
64
Fact sheets
12
Training Material
9
Situation Updates
8
Brochures
1
Infographics
1
Countries / Regions
India
72
Brazil
34
Ethiopia
33
Kenya
30
Nigeria
29
Tanzania
29
Malawi
27
Uganda
27
Sierra Leone
25
Liberia
25
Africa
22
Rwanda
20
Global
20
Ghana
19
Zimbabwe
19
Mozambique
18
Western and Central Europe
18
Zambia
18
Latin America and the Carribbean
17
Nepal
15
Bangladesh
13
Congo, Democratic Republic of
12
West and Central Africa
12
East and Southern Africa
12
Senegal
9
Eastern Europe
9
Syria
8
South Africa
8
Namibia
8
Angola
8
Botswana
8
Ukraine
7
Lesotho
7
Burkina Faso
7
Myanmar / Burma
7
Haiti
6
Cambodia
6
Venezuela
6
Western Pacific Region
6
Middle East and North Africa
5
Russia
5
Indonesia
5
Eswatini/ Swaziland
5
Colombia
4
Guinea
4
USA
4
South–East Asia Region
4
Eastern Europe and Central Asia
4
Cameroon
3
Albania
3
Peru
3
Philippines
3
Guinea-Bissau
3
Germany
3
Iraq
3
Pakistan
3
Togo
2
Afghanistan
2
Asia
2
Turkmenistan
2
Bolivia
2
Argentina
2
Papua New Guinea
2
Sri Lanka
2
Yemen
2
Mali
2
South Sudan
2
Somalia
2
Madagascar
2
Tajikistan
1
Timor Leste/ East Timor
1
Turkey
1
Benin
1
Chile
1
Iran
1
Fiji
1
Burundi
1
Mongolia
1
North America
1
Japan
1
Mauritius
1
Portugal
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Sudan
1
Georgia
1
Central African Republic
1
Chad
1
Libya
1
Bhutan
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
517
Clinical Guidelines
103
Pharmacy & Technologies
79
Key Resources
37
Public Health
35
Women & Child Health
13
Capacity Building
5
Toolboxes
COVID-19
131
TB
110
Rapid Response
83
HIV
80
NTDs
45
AMR
44
Pharmacy
39
Ebola
29
Planetary Health
17
Zika
15
Cholera
14
Caregiver
14
Natural Hazards
13
Conflict
9
Polio
8
Mental Health
7
Health Financing Toolbox
5
Refugee
4
NCDs
3
Global Health Education
3
Specific Hazards
2
Typhoon
1
Human schistosomiasis, a parasitic and often chronic illness, is one of the major neglected tropical diseases worldwide. It is estimated that 240 million people suffer from schistosomiasis, with more than 200000 fatalities recorded each year. Schistosomiasis is caused by an infection of the blood fl...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis: learners’ guide. World Health Organization.
Formation sur le suivi et l’évaluation épidémiologique du traitement médicamenteux de masse pour l’élimination de la filariose lymphatique : guide des apprenants. Organisation mondiale de la Santé.
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagn...
Diagnosis, Case Management Prevention and Control of Leptospirosis
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
MOBILISIERUNG INLÄNDISCHER ÖFFENTLICHER RESSOURCEN FÜR GESUNDHEIT
This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.
Hypertension is referred to as a “silent killer”. Most people with hypertension are unaware of their condition as in most cases, they experience no warning signs or symptoms hence they are not identified or treated. Hypertention is associated with a number of conditions, disability, and causes o...
Diabetes mellitus, commonly known as diabetes, is a group of metabolic disorders characterized by the presence of hyperglycaemia in the absence of treatment. The heterogeneous aetiopathology includes defects in insulin secretion, insulin action, or both. The long-term specific complications of diabe...
Preparedness planning is essential in order to respond effectively to outbreaks, including single case occurrences of highconsequence infectious diseases (HCID), such as the importation of a viral haemorrhagic fever (VHF) case
